Conferences

Catalog

Abstracts

Calendar

2026 Central Illinois Hematology Oncology Conference

Accreditation: 6.00 Nursing Contact Hours | 6.00 ABIM MOC II | 6.00 AMA PRA Category 1 Credit™ | 6.00 ACPE Pharmacy

Venue: Peoria Marriott Pere Marquette, 501 Main Street, Peoria, IL, United States

Start Date: June 20, 2026

Overview

Trusted by Thousands of Attendees
Across Our Events

14+

Email if you have questions

Our Speakers

Faculty

Krishna Rao, MD

Session Chair

Binaytara

Nusayba Bagegni, MD

Session Chair

Binaytara

Kimberly Ku, MD

Session Chair

Binaytara

James Wade, MD

Session Chair

Binaytara

Koosha Paydary, MD

Topic Presenter

Binaytara

Matias Sanchez, MD

Topic Presenter

Binaytara

Parameswaran Venugopal, MD

Topic Presenter

Binaytara

Manish Kohli, MD, MD

Topic Presenter

Binaytara

Ari Rosenberg

Topic Presenter

Binaytara

Noor Naffakh, PharmD

Case Presenter

Binaytara

Nan Sethakorn, MD

Case Presenter

Binaytara

Peng Wang, MD, PhD

Case Presenter

Binaytara

Melanie Barnard, MD

Case Presenter

Binaytara

Tasnem Alsebai

Case Presenter

Binaytara

Nitin Saini

Case Presenter

Binaytara

[email protected]

Case Presenter

Binaytara

Rakesh Mandal, MD

Panelist

Binaytara

Our Agenda

Saturday, June 20th, 2026

All timings are in Central Time (CDT, GMT-05:00) time.

07:00 AM - 08:00 AMRegistration, Breakfast, & Exhibits

08:00 AM - 08:05 AMWelcome & Opening Remarks

08:05 AM - 08:30 AMBinaytara's Efforts in Improving Cancer Health Disparities

08:30 AM - 09:15 AMSession 1: Precision Oncology - Innovations & Foundations

Session Chair: Krishna Rao, MD

08:30 AM - 08:50 AM

Updates in ctDNA – Manish Kohli, MD, MD

08:50 AM - 09:15 AM

Case-Based Discussion – Peng Wang, MD, PhD

09:15 AM - 10:30 AMSession 2: Updates in Hematologic Malignancies

Session Chair: James Wade, MD

09:15 AM - 09:35 AM

Multiple Myeloma management in 2026 – Matias Sanchez, MD

09:35 AM - 09:55 AM

Molecular-Directed Management of Myeloid Disorders

09:55 AM - 10:15 AM

Personalized Treatment in CLL – Parameswaran Venugopal, MD

10:15 AM - 10:30 AM

Panel Discussion

Panelists:

Rakesh Mandal, MD

10:30 AM - 11:00 AMBreak & Exhibits

11:00 AM - 12:00 PMSession 3: Breast Cancer - Tailored Treatments

Session Chair: Nusayba Bagegni, MD

11:00 AM - 11:20 AM

Updates in Breast Cancer

11:20 AM - 11:30 AM

Case Presentation: Hormone Receptor Positive HER2 Negative Breast Cancer – Melanie Barnard, MD

11:30 AM - 11:40 AM

Case Presentation: HER2 Positive Breast Cancer – Nitin Saini

11:40 AM - 11:50 AM

Case Presentation: Triple Negative Breast Cancer – Noor Naffakh, PharmD

11:50 AM - 12:00 PM

Panel Discussion

Moderators:

Nusayba Bagegni, MD

Panelists:

Melanie Barnard, MD; Nitin Saini ; Noor Naffakh, PharmD

12:00 PM - 01:00 PMLunch & Exhibits

01:00 PM - 02:00 PMSession 4: GI Oncology

01:00 PM - 01:20 PM

Management of GI Cancers in the Era of Precision Oncology

01:20 PM - 02:00 PM

Case-Based Discussion: Emerging Targets and Treatment Approaches in GI Oncology – Tasnem Alsebai

02:00 PM - 03:15 PMSession 5: Lung Cancer

02:00 PM - 02:20 PM

Precision-Guided Therapeutics in Lung Cancer – Koosha Paydary, MD

02:20 PM - 02:40 PM

Updates in Head & Neck – Ari Rosenberg

02:40 PM - 03:15 PM

Case-Based Discussion: Biomarker-Driven Treatment in NSCLC – Nan Sethakorn, MD; [email protected]

03:15 PM - 03:45 PMBreak & Exhibits

03:45 PM - 04:30 PMNew EvenSession 6: GU Oncology

Session Chair: Kimberly Ku, MD

03:45 PM - 04:10 PM

Recent Advances in Molecular Guided Treatment of GU Cancers

04:10 PM - 04:30 PM

Case-Based Discussion: Personalizing GU Cancer Management

Acknowledgement of Commercial Support

This activity is supported with an Independent Medical Education grant from Gilead Sciences.

About 2026 Central Illinois Hematology Oncology Conference

Overview

Faculty and committee

Our Speakers

Conference program and agenda

Our Agenda

Venue and map

Accreditations and continuing education

Acknowledgement of Commercial Support

Registration and pricing

Exhibitors and sponsorship

Our Speakers

Our Agenda

Acknowledgement of Commercial Support